Production (Stage)
Candel Therapeutics, Inc.
CADL
$5.05
-$0.11-2.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.38M | -14.07M | -10.65M | -22.24M | -8.22M |
| Total Depreciation and Amortization | 245.00K | 245.00K | 245.00K | 249.00K | 251.00K |
| Total Amortization of Deferred Charges | 44.00K | 52.00K | 62.00K | 73.00K | 83.00K |
| Total Other Non-Cash Items | -14.46M | 7.22M | 2.92M | 15.28M | 1.13M |
| Change in Net Operating Assets | -1.83M | 743.00K | 844.00K | 441.00K | -1.68M |
| Cash from Operations | -8.62M | -5.81M | -6.57M | -6.20M | -8.44M |
| Capital Expenditure | -3.00K | -3.00K | 0.00 | -6.00K | -7.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.00K | -3.00K | 0.00 | -6.00K | -7.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.50M | -2.50M | -2.50M | -2.50M | -1.67M |
| Issuance of Common Stock | 630.00K | 94.41M | 4.18M | 4.45M | 412.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.87M | 91.91M | 1.68M | 1.95M | -1.26M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.49M | 86.10M | -4.90M | -4.26M | -9.70M |